Business Description
Chenguang Biotech Group Co Ltd
NAICS : 325998
ISIN : CNE100000WC5
Share Class Description:
SZSE:300138: Class ACompare
Compare
Traded in other countries / regions
300138.China IPO Date
2011-03-10Description
Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.94 | |||||
| Debt-to-EBITDA | 5.04 | |||||
| Interest Coverage | 8.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.67 | |||||
| Beneish M-Score | -1.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23 | |||||
| 3-Year EBITDA Growth Rate | 23.6 | |||||
| 3-Year EPS without NRI Growth Rate | 26.1 | |||||
| 3-Year Book Growth Rate | 20.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.61 | |||||
| 9-Day RSI | 25.19 | |||||
| 14-Day RSI | 28.84 | |||||
| 6-1 Month Momentum % | -15.82 | |||||
| 12-1 Month Momentum % | -36.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.62 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.72 | |||||
| Days Inventory | 108.31 | |||||
| Days Sales Outstanding | 18.54 | |||||
| Days Payable | 2.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.72 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | -45.4 | |||||
| Forward Dividend Yield % | 1.72 | |||||
| 5-Year Yield-on-Cost % | 3.32 | |||||
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | -11.26 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.85 | |||||
| Operating Margin % | 8.47 | |||||
| Net Margin % | 7.43 | |||||
| FCF Margin % | -11.32 | |||||
| ROE % | 15.07 | |||||
| ROA % | 6.94 | |||||
| ROIC % | 9.62 | |||||
| ROC (Joel Greenblatt) % | 15.59 | |||||
| ROCE % | 15.82 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.14 | |||||
| PE Ratio without NRI | 10.29 | |||||
| Shiller PE Ratio | 21.3 | |||||
| Price-to-Owner-Earnings | 16.35 | |||||
| PEG Ratio | 0.4 | |||||
| PS Ratio | 0.72 | |||||
| PB Ratio | 1.4 | |||||
| Price-to-Tangible-Book | 1.54 | |||||
| Price-to-Operating-Cash-Flow | 196.34 | |||||
| EV-to-EBIT | 12.03 | |||||
| EV-to-EBITDA | 12.03 | |||||
| EV-to-Revenue | 1.12 | |||||
| EV-to-FCF | -42.02 | |||||
| Price-to-Projected-FCF | 1.4 | |||||
| Price-to-DCF (Earnings Based) | 0.31 | |||||
| Price-to-Median-PS-Value | 0.43 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.38 | |||||
| Price-to-Graham-Number | 0.81 | |||||
| Price-to-Net-Current-Asset-Value | 3.61 | |||||
| Earnings Yield (Greenblatt) % | 8.31 | |||||
| FCF Yield % | -15.94 | |||||
| Forward Rate of Return (Yacktman) % | 22.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chenguang Biotech Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 6,871.515 | ||
| EPS (TTM) (Â¥) | 0.903 | ||
| Beta | 0.75 | ||
| Volatility % | 32.61 | ||
| 14-Day RSI | 28.84 | ||
| 14-Day ATR (Â¥) | 0.475522 | ||
| 20-Day SMA (Â¥) | 11.0965 | ||
| 12-1 Month Momentum % | -36.38 | ||
| 52-Week Range (Â¥) | 9.06 - 18.93 | ||
| Shares Outstanding (Mil) | 532.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chenguang Biotech Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chenguang Biotech Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chenguang Biotech Group Co Ltd Frequently Asked Questions
What is Chenguang Biotech Group Co Ltd(SZSE:300138)'s stock price today?
The current price of SZSE:300138 is ¥9.16. The 52 week high of SZSE:300138 is ¥18.93 and 52 week low is ¥9.06.
When is next earnings date of Chenguang Biotech Group Co Ltd(SZSE:300138)?
The next earnings date of Chenguang Biotech Group Co Ltd(SZSE:300138) is .
Does Chenguang Biotech Group Co Ltd(SZSE:300138) pay dividends? If so, how much?
The Dividend Yield %  of Chenguang Biotech Group Co Ltd(SZSE:300138) is 1.72% (As of Today), Highest Dividend Payout Ratio of Chenguang Biotech Group Co Ltd(SZSE:300138) was 3.31. The lowest was 0.05. And the median was 0.19. The  Forward Dividend Yield % of Chenguang Biotech Group Co Ltd(SZSE:300138) is 1.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers